Thus, it is notable that anti-ICOS administration from day 3 of infection, after initial CD4+ T cell priming and differentiation events (39), led to impaired IL-10 production by parasite-specific CD4+ YFP+ T cells. The gene discussed is IL10; the disease is infection.